ICKSH 2024

[JS01] Joint Session 01

Asian Hematology Session I - EBV-associated lymphoid malignancy

Room 1 (Vista Hall 1)

March 28 (Thu), 09:00-10:15
Ki Seong Eom (College of Medicine, The Catholic University of Korea, Korea)
Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
Prospective studies for NK/T-cell lymphoma in Asia Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) Chronic active EBV disease: Our challenge to elucidate the pathogenesis Ayako Arai (St. Marianna University School of Medicine, Japan) NK lymphoma genomics Weili Zhao (Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China) Discussion

[ES01] Education Session 01

Histiocytic neoplasm

Room 2 (Vista Hall 2)

March 28 (Thu), 09:00-10:15
Nack-Gyun Chung (College of Medicine, The Catholic University of Korea, Korea)
Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
Histiocytic neoplasm in pediatrics Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) Histiocytic sarcoma Sung Nam Lim (Inje University College of Medicine, Korea) Pathologic characteristics of histiocytic and dendritic cell neoplasms Sun Och Yoon (Yonsei University College of Medicine, Korea)

[SS01] Scientific Session 01

Exploring the utilization of innovative technologies

Room 3 (Grand Hall 1)

March 28 (Thu), 09:00-10:15
Young Kyung Lee (Hallym University College of Medicine, Korea)
Yoon Hwan Chang (Seoul National University College of Medicine, Korea)
Elucidating the 3D chromatin landscape of pediatric B-cell acute lymphoblastic leukemia using Micro-C Kajsa Paulsson (Lund University, Sweden) Integrated RNA and protein profiling of B-cell acute lymphoblastic leukemia at single-cell level Sungyoung Choi (Hanyang University College of Medicine, Korea) Leveraging dysregulated signaling networks for therapeutic benefit in myeloproliferative neoplasm Stephen T. Oh (Washington University School of Medicine, USA)

[SS02] Scientific Session 02

The unmet needs in CML - Overcoming the obstacles of the road to cure

Room 4 (Art Hall)

March 28 (Thu), 09:00-10:15
Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)
Hawk Kim (Gachon University College of Medicine, Korea)
Molecular mechanism of primary TKI resistance in CML Jerald Radich (Fred Hutchinson Cancer Center, USA) Targeting leukemic stem cells in CML Mhairi Copland (University of Glasgow, UK) The role of NGS to detect TKI resistance Saeam Shin (Yonsei University College of Medicine, Korea)

[PL01] Plenary Lecture 01

Somatic mutations and clonal dynamics in human blood cells

Room 1+2 (Vista Hall 1+2)

March 28 (Thu), 10:30-11:15
Seoklae Chae (Dongguk University College of Medicine, Korea)
Somatic mutations and clonal dynamics in human blood cells Peter J. Campbell (Wellcome Sanger Institute, UK)

[PS01] Presidential Symposium

Lab-on-a-chip in hematology

Room 1+2 (Vista Hall 1+2)

March 28 (Thu), 11:15-12:00
Seongsoo Jang (University of Ulsan College of Medicine, Korea)
Lab-on-a-chip in hematology Chong H. Ahn (University of Cincinnati, USA)

[SY01] Satellite Symposium 01

Janssen

Room 1 (Vista Hall 1)

March 28 (Thu), 12:15-13:05
Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
Treatment of newly diagnosed multiple myeloma: Focus on daratumumab combination Elena Zamagni (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy)

[SY02] Satellite Symposium 02

Astrazeneca

Room 2 (Vista Hall 2)

March 28 (Thu), 12:15-13:05
Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH Sung-Hyun Kim (Dong-A University College of Medicine, Korea)

[SY03] Satellite Symposium 03

Astellas

Room 3 (Grand Hall 1)

March 28 (Thu), 12:15-13:05
Hee-Je Kim (College of Medicine, The Catholic University of Korea, Korea)
Treatment strategies for elderly AML with FLT3-mutation, entering the era of FLT3 Inhibitors Naoko Hosono (University of Fukui, Japan)

[SY04] Satellite Symposium 04

Roche

Room 4 (Art Hall)

March 28 (Thu), 12:15-13:05
Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Advances in the treatment paradigm with bispecific antibodies Wendy Osborne (Newcastle University, UK)

[OP01] Oral Presentation 01

Acute leukemia - 1

Room 1 (Vista Hall 1)

March 28 (Thu), 13:20-14:50
Dae-Young Kim (Ewha Womans University College of Medicine, Korea)
Saeam Shin (Yonsei University College of Medicine, Korea)
The transcriptomic profiles of NPM1 mutated acute myeloid leukemia reveal distinct subtypes characterized by varying clinical outcomes Joon Ho Moon (Kyungpook National University Hospital, Korea) Leukemic stem cells in acute myeloid leukemia further refine treatment outcomes in ELN molecular risk groups Ritu Gupta (All India Institute of Medical Sciences, India) Azacitidine combined with novel flavonoid derivative GL-V9 demonstrated synergistic anti-leukemia effect in acute myeloid leukemia by targeting DDIT4/mTOR signaling Jun Li (Institute of Hematology Southeast University, China) Exploring the genetic landscape of B-ALL: Upregulation of cell adhesion pathway in the high risk adult as com - pared to pediatric B-ALL patients Preity Sharma (All India Institute of Medical Sciences, India) CD371 expression in B-lymphoblastic leukemia and its correlation with recurrent genetic abnormalities Sweta Rajpal (ACTREC, Tata Memorial Centre, India)

[OP02] Oral Presentation 02

Lymphoma

Room 2 (Vista Hall 2)

March 28 (Thu), 13:20-14:50
Ho Sup Lee (Kosin University College of Medicine, Korea)
Youngwoo Jeon (College of Medicine, The Catholic University of Korea, Korea)
Treatment patterns in patients with mantle cell lymphoma: Updated report of the Asia-Pacific multinational retrospective registry study Dok Hyun Yoon (University of Ulsan College of Medicine, Korea) Pooled safety analysis of zanubrutinib monotherapy in Asian patients with B-cell malignancies Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) Prognostic value of end-of-treatment [18F]FDG PET/CT in newly diagnosed patients with primary central ner - vous system lymphoma who respond to first-line treatment with high-dose methotrexate-based regimen Hyungwoo Cho (University of Ulsan College of Medicine, Korea) Efficacy of dexamethasone, L-asparaginase, ifosfamide, carboplatin, and etoposide in patients with relapsed/ refractory peripheral T cell lymphoma Tong Yoon Kim (College of Medicine, The Catholic University of Korea, Korea) Characteristics and outcome of post-transplant lymphoproliferative disease in children treated with low-dose chemotherapy over 20 years in a single hospital Hyery Kim (University of Ulsan College of Medicine, Korea)

[OP03] Oral Presentation 03

Hematopoietic stem cell transplantation & Cellular therapy

Room 3 (Grand Hall 1)

March 28 (Thu), 13:20-14:50
Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
Jieun Uhm (Hanyang University College of Medicine, Korea)
Reduced GVHD incidence with post-transplantation cyclophosphamide in higher-risk myelodysplastic syn - drome Jin-Hee Han (University of Ulsan College of Medicine, Korea) Effect of HLA mismatched on the prognosis of cord blood transplantation for childhood leukemia Lu Liu (Children’s Hospital of Soochow University, China) Interleukin 6 polymorphisms 174 and 597: Impact on graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in childhood Bernd Gruhn (Jena University Hospital, Germany) Reduced 8-Gray versus standard 13.2-gray total dose of total body irradiation based myeloablative conditioning for allogeneic hematopoietic cell transplantation in pediatric acute lymphoblastic leukemia Jae Won Yoo (College of Medicine, The Catholic University of Korea, Korea) High plasmacytoid dendritic cell dose infusion correlates with better plasmacytoid dendritic cell reconstitution and lower incidence of viral infection after transplantation: A single-center study Di Yao (Children’s Hospital of Soochow University, China) BCMA-specific induced pluripotent stem cells and their specific regulatory pathways to differentiate into rejuve - nated antigen-specific memory CD8+ T cells Jooeun Bae (Dana Farber Cancer Institute, USA)

[OP04] Oral Presentation 04

Laboratory hematology

Room 4 (Art Hall)

March 28 (Thu), 13:20-14:50
Sun-Young Kong (National Cancer Center, Korea)
Hyun-Young kim (Sungkyunkwan University School of Medicine, Korea)
Dynamic thrombocytopenia has a negative impact with distinctive genetic and immunologic features in pa - tients with myelofibrosis Tong Yoon Kim (College of Medicine, The Catholic University of Korea, Korea) Ribosomal protein S4X functions as a novel suppressor for SCF complex-mediated ubiquitination of myeloid cell leukemia1 and beta-catenin Satsuki Ryu (Tokushima Bunri University, Japan) Targeted-NGS across the beta-globin gene cluster identifies multiple linkage disequilibrium patterns in north Indian non-transfusion dependent beta-thalassemia patients Prashant Sharma (Research Block A, Postgraduate Institute of Medical Education and Research, India) Novel insight into the role of HTLV-1 unspiced form of bZIP factor: Specific interaction with HS-1 associated protein X-1, preventing caspase9-dependent apoptotic pathway Yuka Tanaka (Tokushima Bunri University, Japan) Immune function of chimeric antigen receptor T cells quantitatively assessed via molecular imaging flow cytom - etry Hiroshi Yasui (The Institute of Medical Science, The University of Tokyo, Japan)

[JS02] Joint Sesseion 02

EHA-KSH Joint Symposium - Multiple myeloma

Room 1 (Vista Hall 1)

March 28 (Thu), 15:05-16:20
Jin Seok Kim (Yonsei University College of Medicine, Korea)
Meral Beksac (Ankara Liv Hospital, Türkiye)
Dynamic assessment of risk in multiple myeloma Meral Beksac (Ankara Liv Hospital, Türkiye) PET/CT for risk stratification in multiple myeloma Joon Ho Moon (Kyungpook National University Hospital, Korea) Bone marrow inflammation in multiple myeloma Tom Cupedo (Erasmus MC Cancer Center, The Netherlands) Single-cell analysis in multiple myeloma Sung-Soo Park (College of Medicine, The Catholic University of Korea, Korea)

[SS03] Scientific Session 03

Wise perspective on new approaches in hemophilia

Room 2 (Vista Hall 2)

March 28 (Thu), 15:05-16:20
Eun Jin Choi (Daegu Catholic University School of Medicine, Korea)
Young Shil Park (Kyung Hee University College of Medicine, Korea)
Approaches to treat people with hemophilia: What’s new and what’s not? Leonard A. Valentino (Rush University, USA) Prospects and challenges of gene therapy for hemophilia Alok Srivastava (Christian Medical College, India) Exploring personalized tailored hemophilia treatment: Tailoring treatment to individual needs Jeong A Park (Inha University College of Medicine, Korea)

[SS04] Scientific Session 04

For the next generation CAR-T cells

Room 3 (Grand Hall 1)

March 28 (Thu), 15:05-16:20
Seok-Goo Cho (College of Medicine, The Catholic University of Korea, Korea)
Je-Jung Lee (Chonnam National University Medical School, Korea)
CD7 CAR-T therapy for treating hematological maligancies Peihua Lu (Lu Daopei Hospital, China) Development of a novel anti-CD19 CAR-T cells in B cell lymphoma Dok Hyun Yoon (University of Ulsan College of Medicine, Korea) CAR-T cells for treatment of T cell malignancies Paul M. Maciocia (Cancer Research UK, UK)

[SS05] Scientific Session 05

Deepened understanding of AML using multi-omics approaches

Room 4 (Art Hall)

March 28 (Thu), 15:05-16:20
Hyeoung-Joon Kim (Chonnam National University Medical School, Korea)
Myungshin Kim (College of Medicine, The Catholic University of Korea, Korea)
Navigating cancer complexities via single-cell omics and AI Manoj Bhasin (Emory University, USA) Targeting the developmental heterogeneity of human acute myeloid leukemia Shanshan Pei (Zhejiang University, China) Mutational profile in Korean AML patients Jae-Sook Ahn (Chonnam National University Medical School, Korea)

[SS06] Scientific Session 06

Insights into lymphoma pathobiology

Room 1 (Vista Hall 1)

March 28 (Thu), 16:35-17:50
Gyeong-Sin Park (College of Medicine, The Catholic University of Korea, Korea)
Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
Germinal center in the genesis of lymphomas Laura Pasqualucci (Columbia University, USA) Genomics of follicular lymphoma: Clinical implications? Robert Kridel (University Health Network, Canada) Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phe - notype: A multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression Jin Ho Paik (Seoul National University College of Medicine, Korea)

[SS07] Scientific Session 07

Profound understanding of diagnosis and therapy in MDS

Room 2 (Vista Hall 2)

March 28 (Thu), 16:35-17:50
Yoo Jin Kim (College of Medicine, The Catholic University of Korea, Korea)
Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
Molecular alterations and clinical implications in MDS Yasushi Miyazaki (Nagasaki University, Japan) Recent advances and future therapeutic strategies in MDS Guillermo Garcia-Manero (The University of Texas MD Anderson Cancer Center, USA) Current diagnostic challenges in MDS In-Suk Kim (Pusan National University School of Medicine, Korea)

[SS08] Scientific Session 08

Leukemogenesis in children and adults

Room 3 (Grand Hall 1)

March 28 (Thu), 16:35-17:50
Kyung Ha Ryu (Ewha Womans University College of Medicine, Korea)
Hoon Kook (Chonnam National University Medical School, Korea)
RUNX1-FPDMM natural history study at NIH Pu Paul Liu (National Institutes of Health, USA) Clinical impact of DDX41 mutations in myeloid neoplasms Talha Badar (Mayo Clinic, USA) Discovery of new regulators in hematopoietic stem cells and malignancies Dongjun Lee (Pusan National University School of Medicine, Korea)

[ES02] Education Session 02

Basics for trainees

Room 4 (Art Hall)

March 28 (Thu), 16:35-17:50
Inho Kim (Seoul National University College of Medicine, Korea)
Jaewoo Song (Yonsei University College of Medicine, Korea)
Overview of lymphoma classification Tae-Jung Kim (College of Medicine, The Catholic University of Korea, Korea) What's new in AML classification Hee Sue Park (Chungbuk National University College of Medicine, Korea) Recent update of MDS classification Miyoung Kim (University of Ulsan College of Medicine, Korea)

[JS03] Joint Session 03

ASH-KSH Joint Symposium - Ped-ALL

Room 1 (Vista Hall 1)

March 29 (Fri), 09:00-10:15
Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
Wendy Stock (University of Chicago, USA)
Pediatric and AYA ALL: Lessons learned from Childern's Onclogy Group clinical trials Sarah K. Tasian (The Children’s Hospital of Philadelphia, USA) Multicenter trials investigating childhood acute lymphoblastic leukemia in South Korea Hyery Kim (University of Ulsan College of Medicine, Korea) Dissecting the developmental origins of acute leukemia Charles G. Mullighan (St. Jude Children’s Research Hospital, USA) Unveiling precision medicine: RNA and DNA sequencing in targeted therapy for Korean pediatric leukemia Myungshin Kim (College of Medicine, The Catholic University of Korea, Korea)

[ES03] Education Session 03

Leaps and hurdles in transfusion medicine (Kor)

Room 2 (Vista Hall 2)

March 29 (Fri), 09:00-10:15
Duck Cho (Sungkyunkwan University School of Medicine, Korea)
Jihyang Lim (College of Medicine, The Catholic University of Korea, Korea)
Comprehensive overview of cell-based artificial platelet production Seung Yeob Lee (Jeonbuk National University Medical School, Korea) Anti-CD38 and anti-CD47 delay timely transfusion Hyungsuk Kim (Seoul National University College of Medicine, Korea) Reappraisal of transfusion-transmitted infections Dae-Hyun Ko (University of Ulsan College of Medicine, Korea)

[SS09] Scientific Session 09

Clonal hematopoiesis: What should we know?

Room 3 (Grand Hall 1)

March 29 (Fri), 09:00-10:15
Myung Geun Shin (Chonnam National University Medical School, Korea)
Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
Clonal hematopoiesis and aging Siddhartha Jaiswal (Stanford University School of Medicine, USA) Clonal hematopoiesis: Implications for cell therapy Adam S. Sperling (Dana-Farber Cancer Institute, USA) Clonal hematopoiesis and metabolic diseases Sung Hee Choi (Seoul National University College of Medicine, Korea)

[SS10] Scientific Session 10

Predictive biomarkers in multiple myeloma

Room 4 (Art Hall)

March 29 (Fri), 09:00-10:15
Chang-Ki Min (College of Medicine, The Catholic University of Korea, Korea)
Jeong Yeal Ahn (Gachon University College of Medicine, Korea)
The impact of immune profiling of T-cell and plasma cells on non-cellular immune therapy in myeloma Nizar Jacques Bahlis (University of Calgary, Canada) Single-cell techniques to characterize immune microenvironment in MM Niels Weinhold (Heidelberg University, Germany) The power of ONE: Immunology in the age of single cell genomics Ido Amit (Weizmann Institute of Science, Israel)

[PL02] Plenary Lecture 02

Plenary Lecture 02

Room 1 (Vista Hall 1)

March 29 (Fri), 10:30-11:15
Chuhl Joo Lyu (Yonsei University College of Medicine, Korea)
How to win: Competitive strategies in the hematopoietic stem cell niche Margaret Goodell (Baylor College of Medicine, USA)

[SY05] Satellite Symposium 05

BMS

Room 1 (Vista Hall 1)

March 29 (Fri), 12:15-13:05
Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Continued hope with ONUREG - A new maintenance therapy to treat AML Esther Oliva (Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Italy)

[SY06] Satellite Symposium 06

Kyowa Kirin

Room 2 (Vista Hall 2)

March 29 (Fri), 12:15-13:05
Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
Mogamulizumab: A new era in MF/SS management - Clinical evidence and practical consideration Francine Foss (Yale University School of Medicine, USA)

[SY07] Satellite Symposium 07

Novartis

Room 3 (Grand Hall 1)

March 29 (Fri), 12:15-13:05
Dong-Wook Kim (Eulji University School of Medicine, Korea)
TKI treatment pattern and new therapy of CML Qian Jiang (Peking University People's Hospital, China)

[SY08] Satellite Symposium 08

Handok

Room 4 (Art Hall)

March 29 (Fri), 12:15-13:05
Hyeon-Seok Eom (National Cancer Center, Korea)
The optimal treatment strategy for transplant-ineligible relapsed/refractory DLBCL Kwai Han Yoo (Gachon University College of Medicine, Korea)

[OP5] Oral Presentation 05

Acute leukemia - 2

Room 1 (Vista Hall 1)

March 29 (Fri), 13:20-14:50
Jeong-Ok Lee (Seoul National University College of Medicine, Korea)
Sung Han Kang (University of Ulsan College of Medicine, Korea)

[OP6] Oral Presentation 06

Multiple myeloma

Room 2 (Vista Hall 2)

March 29 (Fri), 13:20-14:50
Yeung-Chul Mun (Ewha Womans University College of Medicine, Korea)
Sung-Hoon Jung (Chonnam National University Medical School, Korea)
Carfilzomib, lenalidomide, dexamethasone in the real-world Asian relapsed and/or refractory multiple myeloma patients - KMM2201 study Ji Hyun Lee (Dong-A University College of Medicine, Korea) Real-world effectiveness of Ixazomib, lenalidomide, and dexamethasone (IRd) in Asian patients with relapsed/ refractory multiple myeloma (RRMM) Soo Chin Ng (Subang Jaya Medical Centre, Malaysia) Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus Ixazomib, lenalidomide, and dexa - methasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Do Young Kim (Pusan National University School of Medicine, Korea) Bortezomib maintenance therapy in transplant-ineligible newly diagnosed multiple myeloma have major response to induction chemotherapy (KMM 174) Jung Yeon Lee (College of Medicine, The Catholic University of Korea, Korea) Impact of pretransplant measurable residual disease(MRD) using multiparametric flow cytometry(mFCM) and imaging (PET-CT scan) before autologous stem cell transplantation(ASCT) in multiple myeloma : Insights from tertiary centre In India Rudra Nrayan Swain (Post Graduate Institute of Medical Education and Research, India) The efficacy of salvage second autologous hematopoietic stem cell transplantation in Korean patients with relapsed/refractory multiple myeloma in novel agent era: the KMM2301 study Jongheon Jung (National Cancer Center, Korea)

[OP7] Oral Presentation 07

Myeloid neoplasm & Bone marrow failure

Room 3 (Grand Hall 1)

March 29 (Fri), 13:20-14:50
Seong Hyun Jeong (Ajou University School of Medicine, Korea)
Ji Hyun Kwon (Chungbuk National University College of Medicine, Korea)
Efficacy & safety of momelotinib vs danazol in JAKi-experienced patients with myelofibrosis & anemia: Asian subgroup analysis of the MOMENTUM trial Sung-Soo Yoon (Seoul National University College of Medicine, Korea) Distinct molecular and cytogenetic profiles of myelodysplastic syndrome with bone marrow eosinophilia and basophilia Yujin Jung (Seoul National University College of Medicine, Korea) Clinical and molecular characteristics and prognostic significance of autoimmune disease in myelodysplastic syndrome Yunsuk Choi (University of Ulsan College of Medicine, Korea) Haploidentical HCT using ex vivo T cell-depleted PBSC as first-line therapy for pediatric patients with acquired SAA Ho Joon Im (University of Ulsan College of Medicine, Korea) STK10 mutation block erythropoiesis in acquired pure red cell aplasia via down-regulated the ribosome biosyn - thesis Meng Danchen (The First Affiliated Hospital of Anhui Medical University, China)

[OP8] Oral Presentation 08

Thrombocytopenia & Supportive care

Room 4 (Art Hall)

March 29 (Fri), 13:20-14:50
Junshik Hong (Seoul National University College of Medicine, Korea)
Seungmin Hahn (Yonsei University College of Medicine, Korea)
Clinical outcomes of TPO-receptor agonists in patients with steroid-refractory immune thrombocytopenia; Significant conditions of discontinuation with good response Jae-Ho Yoon (College of Medicine, The Catholic University of Korea, Korea) Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombo - cytopenia: A multicenter observational retrospective study in China Zhifa Wang (Beijing Children’s Hospital, China) Effect of anagrelide on health-related quality of life in patients with treatment-nave, high-risk essential thrombo - cythemia Taekeun Park (Seoul National University College of Medicine, Korea) Impact of hematopoietic stem cell transplantation on bone metabolism and growth in pediatric patients with thalassemia major Yu Liu (Shantou University, China) Effects of tertiary palliative care on the pattern of end-of-life care in patients with hematologic malignancies Dong Hyun Kim (Seoul National University College of Medicine, Korea) The clinical manifestation, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hemato - poietic stem cell transplantation Yuewen Wang (Peking University People’s Hospital, China)

[JS04] Joint Session 04

Current interests in hematologic disease in Asia

Room 1 (Vista Hall 1)

March 29 (Fri), 15:05-16:20
Byeong-Bae Park (Hanyang University College of Medicine, Korea)
The journey of bone marrow transplantation at BachMai General Hospital Han Viet Trung (Bach Mai Hospital, Vietnam) Current situation of management of non-Hodgkin lymphoma in the Republic of Armenia Yervand Hakobyan (Armenian Hematology Association, Armenia) The evolution of hemophilia treatment in Thailand Darintr Sosothikul (Chulalongkorn University, Thailand)

[SS11] Scientific Session 11

Quality-of-life revisited

Room 2 (Vista Hall 2)

March 29 (Fri), 15:05-16:20
Sung Yong Oh (Dong-A University College of Medicine, Korea)
Yong Park (Korea University College of Medicine, Korea)
Palliative care for patients with leukemia Min Sun Kim (Seoul National University College of Medicine, Korea) Long-term survivorship in hematologic malignancies Shahrukh K. Hashmi (Mayo Clinic, UAE) The importance of monitoring symptoms and quality of life in routine hematology practice Fabio Efficace (Italian Group for Adult Hematologic Diseases, Italy)

[SS12] Scientific Session 12

Novel approaches for diagnosis & treatment of acute lymphoblastic leukemia

Room 3 (Grand Hall 1)

March 29 (Fri), 15:05-16:20
Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Ho-Jin Shin (Pusan National University School of Medicine, Korea)
Novel approaches for diagnosis & treatment of acute lymphoblastic and myeloid leukemia Michel Zwaan (Princess Máxima Center for Pediatric Oncology, The Netherlands) The role of blinatumomab in the treatment of MRD negative B-ALL in adults Mark R. Litzow (Mayo Clinic, USA) Revised WHO classification of ALL: New era of genetic diagnosis Ari Ahn (College of Medicine, The Catholic University of Korea, Korea)

[ES04] Education Session 04

Monoclonal gammopathies of clinical significance

Room 4 (Art Hall)

March 29 (Fri), 15:05-16:20
Young Rok Do (Keimyung University School of Medicine, Korea)
Hyo Jung Kim (Hallym University College of Medicine, Korea)
AL cardiac amyloidosis Darae Kim (Sungkyunkwan University School of Medicine, Korea) Nephrologist’s perspective on monoclonal gammopathy of renal significance Soon Hyo Kwon (Soonchunhyang University College of Medicine, Korea) Monoclonal gammopathies of neurological significance Ju-Hong Min (Sungkyunkwan University School of Medicine, Korea)

[SS13] Scientific Session 13

Advancing in knowledge of rare pediatric hematologic disorders

Room 2 (Vista Hall 2)

March 29 (Fri), 16:35-17:50
Ho Joon Im (University of Ulsan College of Medicine, Korea)
Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
Clonal evolution of MDS/AML in patients with cancer predisposition syndromes Kenichi Yoshida (National Cancer Center Research Institute, Japan) Congenital and aquired thrombophilic conditions in children Leonardo R. Brandão (University of Toronto, Canada) Management of rare pediatric lymphomas Jae Wook Lee (College of Medicine, The Catholic University of Korea, Korea)

[JS05] Joint Session 05

Asian Hematology Session II - AML

Room 3 (Grand Hall 1)

March 29 (Fri), 16:35-17:50
Sangkyun Sohn (Kyungpook National University School of Medicine, Korea)
Byong Soo Kim (Korea University College of Medicine, Korea)
Epidemiology, risk stratification and treatment outcome in acute myeloid treatment: Taiwan experience Hsin-An Hou (National Taiwan University, Taiwan) Advancement in leukaemia diagnostics: The role of next-generation sequencing (NGS) in acute myeloid leukae - mia in Malaysia Angeli Ambayya (Ministry of Health, Malaysia) Determining fitness for treatments in older adults with AML Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea)

[ES05] Education Session 05

Principles of anticoagulation - All about blood clots (Kor)

Room 4 (Art Hall)

March 29 (Fri), 16:35-17:50
Soo-Mee Bang (Seoul National University College of Medicine, Korea)
Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea)
Back to the basic: Coagulation pathway Seonyang Park (Inje University College of Medicine, Korea) Pharmacology: Anticoagulants and reversal agents Seo-Yeon Ahn (Chonnam National University Medical School, Korea) Proper application of anticoagulation therapy on cancer associated thrombosis Ho-Young Yhim (Jeonbuk National University Medical School, Korea)

[YI] Young Investigator Award Presentation

Room 1 (Vista Hall 1)

March 30 (Sat), 08:00-09:00
Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Comparison Hyunkyung Park (University of Ulsan College of Medicine, Korea) Evaluation of plasma cell sorting methods in multiple myeloma patients: Flow cytometry versus magnetic beads Saeam Shin (Yonsei University College of Medicine, Korea) Comparative analysis of genes according to ropeginterferon alfa-2b treatment response in patients with polycy - themia vera Seug Yun Yoon (Soonchunhyang University College of Medicine, Korea) Single-cell transcriptome analysis to investigate the immune profile of T cells post-allogeneic hematopoietic stem cell transplantation and elucidate mechanisms underlying graft-versus-host disease Jong Hyuk Lee (College of Medicine, The Catholic University of Korea, Korea) Characterization of cytotoxic CD4 T cells to promote cellular immunotherapy outcome in multiple myeloma Hyunsoo Cho (Yonsei University College of Medicine, Korea) A study on the utility of next-generation sequencing-based assays for immunoglobulin gene rearrangement usage repertoire analysis and measu rable residual disease monitoring in B-cell acute lymphoblastic leukemia Daehyun Chu (University of Ulsan College of Medicine, Korea) Clinical impact of NGS-based measurable residual disease as prognostic marker in pediatric acute myeloid leukemia Hyun Jin Park (Seoul National University College of Medicine, Korea) Identification of relapse related clones using minimal residual disease monitoring by next-generation sequenc - ing in Korean pediatric patients with acute myeloid leukemia Jong-Mi Lee (College of Medicine, The Catholic University of Korea, Korea) The impact of the tumor immune microenvironment on the efficacy of CAR T-cell therapy or Bi-specific antibody therapy in relapsed or refractory diffuse large B-cell lymphoma Hyungwoo Cho (University of Ulsan College of Medicine, Korea)

[ES06] Education Session 06

Essential knowledge for optimal hematologic consultation (Kor)

Room 1 (Vista Hall 1)

March 30 (Sat), 09:00-10:15
Jong Ho Won (Soonchunhyang University College of Medicine, Korea)
Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
Functional iron deficiency in cancer patients Ik-Chan Song (Chungnam National University College of Medicine, Korea) Assessment of neutropenia in hospitalized patients Young Hoon Park (Ewha Womans University College of Medicine, Korea) Perioperative consultation for the appropriate transfusion Ka-Won Kang (Korea University College of Medicine, Korea)

[SS14] Scientific Session 14

Novel insights into pathogenesis of MPN

Room 2 (Vista Hall 2)

March 30 (Sat), 09:00-10:15
Chul Won Choi (Korea University College of Mecine, Korea)
Sung-Yong Kim (Konkuk University School of Medicine, Korea)
Myeloproliferative neoplasms and inflammation Steffen Koschmieder (RWTH Aachen University, Germany) Signaling contributing to the development of myelofibrosis: Beyond JAK/STAT Douglas Tremblay (Mount Sinai School of Medicine, USA) Clonal evolution in myelofibrosis Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea)

[SS15] Scientific Session 15

Immunotherapies for lymphomas non-benefited from CAR-T cell

Room 3 (Grand Hall 1)

March 30 (Sat), 09:00-10:15
Jae-Yong Kwak (Jeonbuk National University Medical School, Korea)
Deok-Hwan Yang (Chonnam National University Medical School, Korea)
Treatment options for relapsed/refractory Hodgkin lymphoma after brentuximab vedotin and PD-1 blockade Alex F. Herrera (City of Hope, USA) Aggressive B-cell lymphomas: Immuno-chemotherapies other than CAR-T cell therapies Jason Westin (The University of Texas MD Anderson Cancer Center, USA) Extranodal NK/T cell lymphoma: The immunogenic tumor Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)

[ES07] Education Session 07

Basic genomics for clinical hematologists (Kor)

Room 4 (Art Hall)

March 30 (Sat), 09:00-10:15
Hee-Jin Kim (Sungkyunkwan University School of Medicine, Korea)
In-Suk Kim (Pusan National University School of Medicine, Korea)
Genomic technologies for detecting structural variations in hematologic malignancies Miae Jang (Sungkyunkwan University School of Medicine, Korea) The role of NGS in hematologic malignancies Young-Uk Cho (University of Ulsan College of Medicine, Korea) Germline predisposition to hematologic malignancies Sang Mee Hwang (Seoul National University College of Medicine, Korea)

[PAP01] Plenary Abstract Presentation 01

Plenary Abstract Presentation

Room 1 (Vista Hall 1)

March 30 (Sat), 10:30-11:15
Dong Yeop Shin (Seoul National University College of Medicine, Korea)
Yoon Seok Choi (Korea University College of Medicine, Korea)
A single-arm, open-label, multicenter study to assess molecular response of P1101 therapy in patients with polycythemia vera and elevated hematocrit: Results from 48 weeks core study Sung-Eun Lee (College of Medicine, The Catholic University of Korea, Korea) Novel genomic variants influencing methotrexate delayed excretion in pediatric patients with acute lympho - blastic leukemia Jung Yoon Choi (Seoul National University College of Medicine, Korea) Prognostic utility of minimal residual disease (MRD) after curative intent induction therapy for DLBCL: A prospec - tive real-world ctdna study Sang Eun Yoon (Sungkyunkwan University School of Medicine, korea)

Scientific Program

Sponsored by